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Abstract: The developmental neurotoxicity of organophosphates involves
mechanisms other than their shared property as cholinesterase inhibitors,
among which are excitotoxicity and oxidative stress. We used PC12 cells as a
neurodevelopmental model to compare the effects of chlorpyrifos and
diazinon on the expression of genes encoding glutamate transporters.
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induced neurodifferentiation as compared to undifferentiated PC12 cells, with
peak sensitivity at the initiation of differentiation, reflecting a global
upregulation of all the glutamate transporter genes expressed in this cell line.
In differentiating cells, chlorpyrifos had a significantly greater effect than did
diazinon and concordance analysis indicated no resemblance in their
expression patterns. At the same time, the smaller effects of diazinon were
highly concordant with those of an organochlorine pesticide (dieldrin) and a
metal (divalent nickel). We also performed similar evaluations for the
cystine/glutamate exchanger, which provides protection against oxidative
stress by moving cystine into the cell; again, chlorpyrifos had the greatest
effect, in this case reducing expression in undifferentiated and differentiating
cells. Our results point to excitotoxicity and oxidative stress as major
contributors to the noncholinesterase mechanisms that distinguish the
neurodevelopmental outcomes betweem different organophosphates while
providing a means whereby apparently unrelated neurotoxicants may produce
similar outcomes.
Keywords: Chlorpyrifos, Diazinon, Dieldrin, Gene transcription patterns,
Glutamate transporters, Microarrays, Nickel, Organochlorine insecticides,
Organophosphate insecticides, PC12 cells

Introduction
Organophosphates are the most widely-used insecticides but are
undergoing increasing scrutiny because of their propensity to elicit
developmental neurotoxicity [10,11,16,35,47]. As predicted by the
results of laboratory studies over the past two decades, recent
evaluations in human populations confirm a specific relationship
between exposure to organophosphates and neurodevelopmental
delays, depression and attention deficit hyperactivity disorder
[6,7,24,42]. Originally, it was thought that these agents acted solely
through inhibition of cholinesterase, so that exposure and toxicity
could both be monitored readily by measuring the activity of this
enzyme in plasma or red blood cells [36]. However, it is increasingly
evident that organophosphates produce neurodevelopmental deficits
below the threshold for signs of exposure or even without a detectable
reduction in cholinesterase [11,47]. If organophosphates act through
mechanisms other than their shared anticholinesterase properties, the
various members of this class may differ in their ability to act as
developmental neurotoxicants, and it then becomes important to
identify the degree to which the different organophosphates target
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those mechanisms. We recently showed that chlorpyrifos and diazinon,
two of the most commonly-used organophosphates, differ substantially
in their ability to elicit oxidative stress or excitotoxicity, with
chlorpyrifos producing much larger changes in ionotropic glutamate
receptor gene expression, whereas diazinon evoked greater effects on
genes involved in apoptosis [50,54]. A subsequent paper pointed to
further differences directed toward glutamate uptake and release and
suggested the need to evaluate their comparative effects on glutamate
transporters [44], the subject of the current study.
Our evaluations were conducted in PC12 cells, a widely-used in
vitro model for neuronal development [64] that reproduces the
mechanisms and outcomes of in vivo organophosphate exposures
[3,4,13–15,18,25,26,33,37,39,40,49,50,59,60,62,66]. Nerve growth
factor triggers differentiation of PC12 cells into neuronal phenotypes
[20,62,64] and, like neurons, PC12 cells express the family of
glutamate transporters that play an important role in the response to
excitotoxic injury and oxidative stress, recapitulating the same
functions as in the central nervous system [1,19,27,30,31,68].
Similarly, PC12 cells also possess the cystine/glutamate exchanger,
which provides antioxidant protection by moving cystine into the cell in
return for moving glutamate outwards [38].
For chlorpyrifos, we evaluated the effects in the undifferentiated
state and during differentiation; we then compared the effects during
differentiation with those of diazinon. Finally, we contrasted the effects
of the organophosphates with those unrelated developmental
neurotoxicants, the organochlorine insecticide, dieldrin, and a metal,
divalent nickel. In our earlier work, we unexpectedly found similarities
between their effects and those of organophosphates with regard to
oxidative stress, excitotoxicity, cell signaling, neurotrophic responses
and neurodifferentiation [2,50,53–57,60]. These additional test agents
have intrinsic interest because of environmental concerns about
human exposure and safety. Dieldrin is known to produce
developmental neurotoxicity [8,28,29,34,50,67]; nickel shows fetal
accumulation similar to that of lead [9,23] and shares neurotoxic
actions with lead and cadmium [5]. For our evaluations, we used
microarrays in a “planned comparisons” framework, where genes are
selected based on a specific pathway and hypothesis prior to
examining the microarray data, rather than the other way around; the
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advantages and limitations of this approach as compared to searches
of the entire genome have been presented previously [52,56,58–60].
Here, we restricted our examination to the glutamate transporter
family. In addition to examining up- and downregulation of the
glutamate transporter genes, we also assessed concordance between
pairs of agents to determine overall similarities of the transcriptional
responses [2,54,60].

Methods
Cell cultures
Because of the clonal instability of the PC12 cell line [20], the
experiments were performed on cells that had undergone fewer than
five passages. As described previously [41,62], PC12 cells (American
Type Culture Collection, CRL-1721, obtained from the Duke
Comprehensive Cancer Center, Durham, NC) were seeded onto polyD-lysine-coated plates in RPMI-1640 medium (Invitrogen, Carlsbad,
CA) supplemented with 10% horse serum (Sigma Chemical Co., St.
Louis, MO), 5% fetal bovine serum (Sigma), and 50 μg/ml penicillin
streptomycin (Invitrogen). Incubations were carried out with 7.5% CO2
at 37°C, standard conditions for PC12 cells. To initiate
neurodifferentiation [25,50,64] twenty-four hours after seeding, the
medium was changed to include 50 ng/ml of 2.5 S murine nerve
growth factor (Invitrogen). Along with the nerve growth factor, we
added 30 μM of each of the test agents: chlorpyrifos (Chem Service,
West Chester, PA), diazinon (Chem Service), dieldrin (Chem Service)
or NiCl2 (Sigma). The concentration was chosen from earlier studies
that demonstrated adverse effects on differentiation of PC12 cells
without outright cytotoxicity [26,39,50,59]. Because of the limited
water solubility of the three insecticides, these agents were dissolved
in dimethylsulfoxide (final concentration 0.1%), which was also added
to the control cultures and to cultures containing NiCl2; this
concentration of dimethylsulfoxide has no effect on PC12 cell growth or
differentiation [39,41,62]. Cultures were examined 24 and 72 hr after
commencing exposure, with 5–8 independent cultures evaluated for
each treatment at each time point. Each culture was run on a separate
array. We used two time points so as to be able to evaluate changes in
gene expression regardless of whether the mRNA for a given gene has
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a rapid turnover (and hence can rise rapidly) or a slower turnover that
would require a longer period to show corresponding increases or
decreases. For chlorpyrifos, we evaluated the effects both on
undifferentiated cells (without addition of nerve growth factor) and
during differentiation, whereas for the other agents, we studied the
effects only during differentiation.

Microarray determinations
Our earlier studies detailed the techniques for mRNA isolation,
preparation of cDNA, conversion to cRNA incorporating cyanine-3
(reference RNA) or cyanine-5 (sample RNA), verification of RNA purity
and quality, hybridization to the microarrays, washing and scanning
[52,58,59]. These all involve commercial kits and standardized
procedures, and since the current studies were done identically, the
techniques will not be described here. The mRNA used for the
reference standard was created by pooling aliquots from each of the
samples in the study so as to ensure measurable levels of all genes
expressed over the background. Array normalizations and error
detection were also carried out by standard procedures described
previously [52,58,59]. We used Agilent Whole Rat Genome Arrays
(Agilent Technologies, Palo Alto, CA), type G4131A for the studies of
chlorpyrifos in undifferentiated and differentiating cells, whereas type
G4131F was used for the studies of diazinon, dieldrin and Ni2+ in
differentiating cells. The two chips contain exactly the same gene
sequences but the latter has a lower detection threshold; however, all
the genes reported here passed the quality control filters with both
arrays.
For several of the genes, the arrays contain multiple probes
and/or replicates of the same probe in different locations on the chip,
and these were used to verify the reliability of values and the validity
of the measures on the chip. In these cases, to avoid artificially
inflating the number of genes utilized for analysis, we limited each
gene to a single set of values, selecting those obtained for the probe
showing the smallest intragroup variance. The other values for that
gene were used only to corroborate direction and magnitude of
change. We also validated the readings on the arrays through the use
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of duplicate arrays for one sample selected from each treatment group
[52,58].

Statistical procedures
Because of the requirement to normalize the data across arrays,
the absolute values for a given gene are meaningless, so only the
relative differences between treatments can be compared. Our design
involved planned comparisons of four agents at two time points, as
well as the effects of one agent (chlorpyrifos) in undifferentiated vs.
differentiating states. It was therefore important to protect against the
increased probability of type 1 errors engendered by repeated testing
of the same data base. Accordingly, before looking at effects on
individual genes, we performed a global ANOVA incorporating all the
variables in a single comparison: treatment, time, and all genes.
Lower-order ANOVAs on subdivisions of the data set were then carried
out as permitted by the interactions of treatment with the other
variables. Differences for individual treatments for a specified gene at
a single time point were evaluated with Fisher’s Protected Least
Significant Difference. However, for a given gene where there was no
interaction of treatment with other variables (time, differentiation
state), only the main treatment effect was reported without subtesting
of effects at a single time point. Treatment effects were considered
significant at p < 0.05 (two-tailed, since we were interested in both
increases and decreases in gene expression).
To compare overall patterns of effects on gene expression, as
distinguished from just identifying individual genes targeted by the
treatments, we evaluated concordance between treatments by plotting
the percentage change from control and calculating the linear
correlation coefficient between pairs of agents [2,54,60].

Results
The microarrays revealed significant expression of eight
glutamate transporters that passed the quality control procedures
(Table 1), including those related to neurons (slc1a1), synaptic
vesicles (vglut3) and glia (slc1a2, slc1a3), as well as those
transporting glutamate into multiple cell types (slc1a7), glutamate as
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a neutral amino acid (slc1a4, slc1a5) or aspartate/glutamate (slc1a6).
In addition, we were able to measure expression of the
cystine/glutamate exchanger (slc7a11), which we considered
separately from the glutamate transporter family. Because only one
agent (chlorpyrifos) was tested in both undifferentiated and
differentiating cells, we conducted two sets of global statistical tests.
For chlorpyrifos, the ANOVA factors were treatment, differentiation
state, time and gene, and we found a main treatment effect (p <
0.007) as well as interactions of treatment × differentiation state ×
time (p < 0.03), treatment × time (p < 0.04) and treatment × time ×
gene (p < 0.02). Accordingly, we subdivided the results for
presentation according to differentiation state and performed lowerorder tests to identify main effects and interactions with the remaining
variables (time, gene). Diazinon, dieldrin and Ni2+ were studied only in
differentiating cells, so the ANOVA factors for these agents were
treatment, gene and time. The global test identified significant
interactions of treatment × time (p < 0.02) and treatment × gene ×
time (p < 0.009), so we subdivided the data into the individual
treatments for presentation and lower-order tests.

In undifferentiated cells, chlorpyrifos elicited selective changes
in the expression of glutamate transporter genes (Figure 1). There was
a robust but transient increase in slc1a3 and smaller, but more
sustained increases for slc1a4 and slc1a5, whereas vglut3 was
decreased. The pattern was quite different for cells undergoing
differentiation (Figure 2A). Here, chlorpyrifos evoked a significant,
global upregulation (main treatment effect) that was significantly
greater at 24h of exposure than at 72h (treatment × time interaction)
but that was nevertheless statistically significant at either of the time
points. Diazinon had a much smaller effect on glutamate transporter
gene expression than did chlorpyrifos (Figure 2B). There was no
global, main treatment effect but rather, there were smaller, geneand time-specific changes confined to slc1a4 (transient increase),
Brain Research Bulletin, Vol. 83, No. 1-2 (August 2010): pg. 76-83. DOI. This article is © Elsevier and permission has been
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be
further copied/distributed or hosted elsewhere without the express permission from Elsevier.

7

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

slc1a5 (small but consistent increase) and vglut3 (decrease at 72h).
Likewise, dieldrin (Figure 2C) had only small effects limited to a single
significant change (slc1a5), as did Ni2+ (Figure 2D), which affected the
same gene.

Figure 1

Effects of chlorpyrifos exposure on expression of genes for glutamate

transporters in undifferentiated PC12 cells. Multivariate ANOVA appears at the top of
the panel and asterisks shown below each gene denote a significant main treatment
effect; daggers denote genes for which a treatment × time interaction was detected
and show the individual times for which treatment effects were present. Expression
ratios in the control group were: slc1a1, 1.12 ± 0.05 at 24h, 1.25 ± 0.06 at 72h;
slc1a2, 1.04 ± 0.08 at 24h, 0.99 ± 0.12 at 72h; slc1a3, 0.72 ± 0.06 at 24h, 1.28 ±
0.09 at 72h; slc1a4, 0.80 ± 0.07 at 24h, 0.96 ± 0.08 at 72h; slc1a5, 0.84 ± 0.01 at
24h, 0.90 ± 0.01 at 72h; slc1a6, 0.86 ± 0.07 at 24h, 1.03 ± 0.06 at 72h; slc1a7,
0.99 ± 0.06 at 24h, 1.04 ± 0.06 at 72h; vglut3, 1.18 ± 0.09 at 24h, 1.05 ± 0.10 at
72h.
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Figure 2

Effects of different neurotoxicants on genes for glutamate transporters in

differentiating PC12 cells: (A) chlorpyrifos, (B) diazinon, (C) dieldrin, (D) Ni 2+.
Multivariate ANOVA appears at the top of each panel. Where there was a significant
difference in the treatment effects on the various genes (B,C,D), asterisks shown
below each gene denote a significant main treatment effect; daggers denote genes for
which a treatment × time interaction was detected and show the individual times for
which treatment effects were present. Where there was only a treatment effect and
interaction of treatment × time (A), the treatment effects for each time are shown
within the legend box. Expression ratios in the control group were: slc1a1, 0.79 ±
0.08 at 24h, 0.94 ± 0.10 at 72h; slc1a2, 1.16 ± 0.09 at 24h, 1.36 ± 0.10 at 72h;
slc1a3, 0.57 ± 0.06 at 24h, 0.95 ± 0.08 at 72h; slc1a4, 0.83 ± 0.09 at 24h, 1.09 ±
0.08 at 72h; slc1a5, 1.13 ± 0.04 at 24h, 0.99 ± 0.03 at 72h; slc1a6, 0.87 ± 0.09 at
24h, 0.84 ± 0.02 at 72h; slc1a7, 0.98 ± 0.03 at 24h, 0.96 ± 0.04 at 72h; vglut3, 1.12
± 0.06 at 24h, 0.93 ± 0.08 at 72h.

To verify that the greater effects of chlorpyrifos in the
differentiating cells were not solely dependent on the one
determination showing the largest increase (slc1a3 at 24h), we
performed paired comparisons using the Wilcoxon signed-rank test so
as to give equal weight to the differences between treatments for each
gene regardless of the absolute magnitude of the individual effect.
Chlorpyrifos exposure in differentiating cells had a greater net effect
than in undifferentiated cells (p < 0.008). Similarly, chlorpyrifos had a
greater effect than diazinon (p < 0.005), dieldrin (p < 0.03) or Ni2+ (p
< 0.003), whereas comparisons among the other three agents showed
no significant distinction from each other. We further examined
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similarities and differences among the treatments by evaluating the
pairwise concordance across all the gene and time measurements; this
procedure assesses patterns of effects incorporating all genes and time
points, regardless of whether the effects were individually significant.
Although there was a significant correlation between effects of
chlorpyrifos in undifferentiated vs. differentiating cells, the entire
relationship depended on a single measurement out of the 16 values,
making it unlikely that the responses were biologically related (Figure
3A). Similarly, there was no detectable relationship between the
pattern of effects for chlorpyrifos in differentiating cells vs. either
diazinon (Figure 3B), dieldrin (Figure 3C) or Ni2+ (Figure 3D). On the
other hand, there was highly-significant concordance between the
effects of diazinon and dieldrin (Figure 4A), diazinon and Ni2+ (Figure
4B) and dieldrin and Ni2+ (Figure 4C).

Figure 3

Pairwise correlations of the effects of chlorpyrifos in undifferentiated vs.

differentiating cells (A), and in differentiating cells for chlorpyrifos vs. diazinon (B),
dieldrin (C) or Ni2+ (D). In (A), a single point (slc1a3 at 1h, arrow) is responsible for
the significant correlation; without that point, R = 0.20, not significant (NS).
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Figure 4

Pairwise correlations of the effects of diazinon vs. dieldrin (A), diazinon

vs. Ni2+ (B) and dieldrin vs. Ni2+ (C) in differentiating cells. Linear correlation
coefficients are shown at the top of each panel along with the least-squares fit.

Chlorpyrifos also had greater effects than the other agents
toward expression of slc7a11, the cystine/glutamate exchanger (Figure
5). For this gene, undifferentiated cells showed strong and persistent
suppression by chlorpyrifos whereas the differentiating cells were
affected to a smaller, but still significant degree. None of the other
agents suppressed slc7a11 expression and indeed, dieldrin evoked a
significant increase at 72h.
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Figure 5

Effects of neurotoxicants on expression of the cystine/glutamate

exchanger, slc7a11. Multivariate ANOVA indicates a significant main treatment effect
(p < 0.0007) and a treatment × time interaction (p < 0.02). Asterisks denote
treatments showing a main effect compared to control; the dagger denotes a
significant treatment × time interaction and shows the individual time for which the
treatment effect was present. Expression ratios in the control group were:
undifferentiated cells, 2.09 ± 0.10 at 24h, 1.43 ± 0.15 at 72h; differentiating cells,
1.47 ± 0.12 at 24h, 0.92 ± 0.09 at 72h.

Discussion
Results obtained in this study reinforce the idea that, despite
their shared property as cholinesterase inhibitors, organophosphates
can differ substantially in their ability to evoke developmental
neurotoxicity through noncholinesterase mechanisms [10,12,22,47].
Here, we identified effects involving the glutamate transporters found
in the synaptic cell membrane (the seven slc1a genes) and that are
thus responsible for removing extracellular glutamate, as well as one
of the vesicular transporters (vglut3) that moves glutamate from the
cytoplasm into synaptic vesicles; these transporters are among the
most important factors that limit excitotoxicity resulting from
glutamate release. We found a much greater effect of chlorpyrifos than
diazinon, a result is in keeping with distinctions between the two
organophosphates in their impact on ionotropic glutamate receptors
[54] and in the response to NMDA receptor antagonists, which protect
cells from chlorpyrifos but not diazinon [44]. It is particularly notable
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that the effects of chlorpyrifos on glutamate transporters was greatest
during the early stages of neurodifferentiation; in our previous work
with ionotropic glutamate receptors, we found greater sensitivity for
undifferentiated PC12 cells. This dichotomy implies that chlorpyrifosinduced excitotoxicity is likely to involve an extended range of
developmental stages but with different underlying mechanisms for
each stage. Indeed, the existence of such multiple mechanisms is one
of the reasons that the developing brain is vulnerable to disruption by
chlorpyrifos virtually throughout development, from the neural tube
stage through late synaptic modeling and gliogenesis [46,47].
Although chlorpyrifos caused global upregulation of glutamate
transporter gene expression, it downregulated the gene encoding the
cystine/glutamate exchanger (slc7a11) in both undifferentiated and
differentiating PC12 cells, but with greater effects in the former.
Clearly, then, this involves a distinctly different mechanism from that
mediating the effect on the transporters and more closely resembles
the prior results for ionotropic glutamate receptors [54]. The
cystine/glutamate exchanger moves cystine into the cell and
glutamate out, with the subsequent intracellular formation of
glutathione providing an important component of antioxidant defense.
Organophosphates elicit oxidative stress as one of their
noncholinesterase mechanisms of neurotoxicity [21,22,50,54,57] and
hence, suppression of the exchanger could easily impair the ability of
neuronal cells to withstand exposure. We are currently examining the
function of the exchanger in primary mouse cortical cultures and, as
predicted from the transcriptional effects seen here, our preliminary
data indicate a clear-cut suppression of activity in response to an
otherwise nontoxic, 24h chlorpyrifos exposure, (17 ± 4 percent
reduction in [14C]cystine uptake, p < 0.006, n=20). Impaired
cystine/glutamate exchange is particularly important in the developing
brain because it has lower reserves of antioxidants [22], and is
deficient in glia, which ordinarily protect neurons from oxidative
molecules [63], while facing the higher metabolic demand associated
with growth. Further, the fetal environment is hypoxic relative to that
of the neonate or adult [17,32], thus fostering the conditions for
oxidative stress. Again, chlorpyrifos was far more active than diazinon
in downregulating the cystine/glutamate exchanger, potentially
exacerbating the consequences of its effects on oxidative stress, as
well as on glutamate release and transport.
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Although it might be expected that chlorpyrifos and diazinon
would be the most similar of the four toxicants evaluated here, we
actually found that the effects of diazinon more closely resembled
those of dieldrin and Ni2+. For the glutamate transporters, there was
highly-significant concordance among diazinon, dieldrin and Ni2+ but
not for any of these agents with chlorpyrifos. This continues a pattern
that we identified in earlier studies comparing organophosphates to
other toxicants with regard to oxidative stress, cell signaling cascades,
neurotrophins and their receptors and neurodifferentiation endpoints
[2,50,53–57,60]. The conclusion is inescapable: apparently unrelated
developmental neurotoxicants can nevertheless converge on quite
similar downstream mechanisms of neurotoxicity, despite any
underlying differences in their chemical composition or initial
mechanism. In turn, this implies that any single specific mechanism of
action may be less important for neurotoxic outcomes than
examination of downstream events known to participate in
neurotoxicity. At the same time, it should then be possible to design
countermeasures that can ameliorate or prevent neurotoxicity from
otherwise disparate neurotoxicants by focusing on the downstream
targets.
In this study, we used planned comparisons of specific pathways
targeted by the neurotoxicants and analyzed the data through the
determination of shared properties (i.e. a standard “principal
components” approach); the rationale for this has appeared previously
[52,58,59] but is worth repeating here. Planned comparisons and
pathway analysis are distinct from the use of microarrays to find a
handful of genes that are affected the most, within the global
examination of the tens of thousands of genes present on the
microarrays. Planned comparisons are based instead on testing a
specific hypothesis that centers around a defined set of genes, and
rests on known, validating outcomes from prior work, in this case for
the organophosphates. With examination of the entire genome,
verification via RT-PCR and other techniques is required because the
enormous number of comparisons generates many false positive
findings (e.g. the >2000 genes that would be false positives if we had
considered all 42,000 probes on the array). For our study, we
compared only a few genes that would generate less than a single
false positive, and for interpretation, we relied on concordance
patterns to evaluate the overall spectrum of multiple gene changes for
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each agent, rather than changes in any one gene; further, we made
sure that effects were repeated across different treatments and/or
different times; even for individual genes, there were multiple probes
and multiple spots on a given array (see Methods), so the changes
cannot be “chance.” Indeed, one of the key points of this study is to
demonstrate that a planned comparisons approach may provide a
superior strategy for the use of microarray data, provided that the
relevant target pathways can be selected in advance, based on specific
hypothesis and prior data.
Our findings strengthen the view that, despite their common
characteristic as cholinesterase inhibitors, organophosphates differ in
their underlying mechanisms of developmental neurotoxicity, in this
case involving glutamate. The dichotomy between the effects of
chlorpyrifos and diazinon on glutamate transporter genes and on the
cystine/glutamate exchanger are likely to play an important role in the
greater susceptibility of developing neurons to chlorpyrifos-induced
excitotoxicity [44,54], and ultimately in the different patterns of
synaptic damage and behavioral deficits seen with each agent
[39,43,45–48,50,51,56,61,65]. At the same time, we found surprising
concordance in the effects of diazinon with unrelated neurotoxicants,
dieldrin and Ni2+, indicating these dissimilar compounds nonetheless
converge on common final pathways of neurotoxicity. These results
with an in vitro system can thus guide future in vivo studies to
evaluate the role of excitatory mechanisms in the developmental
neurotoxicity of organophosphates and other toxicants and to design
appropriate treatments that may protect the developing brain from
injury.
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